Hikma Pharmaceuticals

Hikma Pharmaceuticals plc, headquartered in London, UK, is a British multinational pharmaceutical firm that develops non-branded generic and in-licensed pharmaceutical medicines. Samih Darwazah established it in Amman, Jordan in 1978. It was the first Arab firm to export pharmaceutical products to the United States in August 1996.

By developing high-quality medicines and making them available to those in need, the company helps to shape a healthier world that benefits all of its communities. Three distinct businesses the company provide to the market include generic injectable products; branded generics and in-licensed patented products; oral and other non‑injectable generic and specialty products.

It is a trusted, trustworthy partner and dependable provider of over 760 high-quality generic, specialty, and branded medicinal products that hospitals, physicians, and pharmacists in North America, the Middle East, and Europe require to treat their patients. We have 32 manufacturing facilities, 8 research and development centers, and around 8,800 workers globally.

Founded: 1978
Headquarters: London, England, UK
Website: https://www.dechra.com/